Alzheimer's disease: the tacrine legacy

被引：22

作者：

Kelly, JS ^{[1
]}

机构：

[1] Univ Edinburgh, Fujisawa Inst Neurosci, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1999年 / 20卷 / 04期

关键词：

D O I：

10.1016/S0165-6147(99)01344-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：127 / 129

页数：3

共 13 条

[1]

AITKEN SP, 1996, ADV PHARMACOL, V35, P349

[2]

Bodick NC, 1997, ALZ DIS ASSOC DIS, V11, pS16

[3] The neuropsychiatric inventory: Assessing psychopathology in dementia patients [J].

Cummings, JL .

NEUROLOGY, 1997, 48 (05) :S10-S16

[4] Safety of tacrine: Clinical trials, treatment IND, and postmarketing experience [J].

Gracon, SI ;

Knapp, MJ ;

Berghoff, WG ;

Pierce, M ;

DeJong, R ;

Lobbestael, SJ ;

Symons, J ;

Dombey, SL ;

Luscombe, FA ;

Kraemer, D .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (02) :93-101

[5]

Kumar R, 1997, ALZHEIMER'S DISEASE: BIOLOGY, DIAGNOSIS AND THERAPEUTICS, P677

[6] Effects of a cognition-enhancer, linopirdine (DuP 996), on M-type potassium currents (I-K(M)) and some other voltage- and ligand-gated membrane currents in rat sympathetic neurons [J].

Lamas, JA ;

Selyanko, AA ;

Brown, DA .

EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (03) :605-616

[7] Nicotinic acetylcholine involvement in cognitive function in animals [J].

Levin, ED ;

Simon, BB .

PSYCHOPHARMACOLOGY, 1998, 138 (3-4) :217-230

[8] METHODOLOGICAL ASPECTS OF EVALUATING EFFECTS OF AD PROGRESSION [J].

MOHS, RC .

NEUROBIOLOGY OF AGING, 1995, 16 (06) :867-870

[9] CORRELATION OF CORTICAL CHOLINERGIC AND GABA DEFICITS WITH QUANTITATIVE NEUROPATHOLOGICAL FINDINGS IN SENILE DEMENTIA [J].

MOUNTJOY, CQ ;

ROSSOR, MN ;

IVERSEN, LL ;

ROTH, M .

BRAIN, 1984, 107 (JUN) :507-518

[10]

ORGOGOZO JM, 1998, ALZHEIMER REPORTS S1, V1, pS1

← 1 2 →